<DOC>
	<DOCNO>NCT01544504</DOCNO>
	<brief_summary>This study , nonrandomized open-label safety exploratory study , evaluate safety topical norepinephrine post-surgical breast cancer patient undergo radiation therapy . The study also provide information whether topical norepinephrine prevent decrease severity radiation dermatitis experience patient .</brief_summary>
	<brief_title>Exploratory Study Topical Norepinephrine Breast Cancer Patients Receiving Radiotherapy</brief_title>
	<detailed_description />
	<mesh_term>Radiodermatitis</mesh_term>
	<mesh_term>Norepinephrine</mesh_term>
	<criteria>Subjects must : 1. ≥ age 18 year age document pathological diagnosis Stage Ia ( T1 , N0 , M0 ) , Stage Ib ( T0 1 , N1mic , M0 ) , Stage IIA ( T0T1N1M0 , T2N0M0 ) Stage IIB ( T2N1M0 , T3N0M0 ) infiltrate ductal lobular carcinoma breast ductal carcinoma situ ( DCIS ) . 2. postsurgical patient schedule treat least 50 Gy whole breast axilla use standard radiation technique ( additional 1016 Gy boost lumpectomy region may also deliver ) . All radiation treatment deliver base standard CT planning . 3. high average risk radiodermatitis , evidence separation posterior tangent field border ≥ 24 cm bra cup size C great [ breast size criterion ] . 4. ability understand inform consent document . 5. able comply protocol schedule . 6. negative serum pregnancy test ( within 7 day prior start radiation therapy ) , female child bear potential . 7. consent utilize medically acceptable method contraception throughout study period childbearing potential . Subjects : 1. unhealed surgical wound scar study treatment area . 2. underlie active untreated cardiac disease ( e.g . arrhythmia ) . 3. generalized skin disorder require treatment within past 6 month . 4. connective tissue disorder . 5. rash , ulceration , poorly heal scar study drug application area . 6. know allergy norepinephrine . 7. know clinically significant abnormal ECG within past 6 month . If Principal Investigator feel ECG finding clinical significance , patient exclude sent cardiac consult ( insignificant abnormality sinus tachycardia sinus bradycardia may allow discretion Principal Investigator ) . 8. receive MAO inhibitor antidepressant ( triptyline imipramine type ) . 9. pregnant breastfeeding . 10. lymphovascular space invasion pathology . 11. dermal lymphatic invasion pathology . 12. close proximity tumor overlie skin within SDAS ( evidence depth less 5 mm ultrasound MRI [ perform ] linear distance le 2 cm SDAS ) , diagnosis inflammatory breast cancer . 13. receive concurrent neoadjuvant adjuvant chemotherapy breast cancer . 14. previous radiation breast treat . 15. take βblockers . 16. NCI CTC Version 4.0 grade 2 high hypertension time study entry .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Radiodermatitis</keyword>
	<keyword>Prevention</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Breast</keyword>
	<keyword>Radiation Dermatitis</keyword>
</DOC>